Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
43 studies found for:    Open Studies | "Hemangioma"
Show Display Options
Rank Status Study
21 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
22 Not yet recruiting Interest of New MRI Sequences After Embolization of Brain Arteriovenous Malformations
Condition: Brain Arteriovenous Malformations
Intervention:
23 Recruiting Long Term Follow-up After Embolization of Brain Arteriovenous Malformations
Condition: Arteriovenous Malformations
Intervention:
24 Recruiting Effect of Dexmedetomidine Combined With Sufentanil for Postoperative Intravenous Analgesia in Neurosurgery
Condition: Arteriovenous Malformation
Interventions: Drug: Sufentanil;   Drug: dexmedetomidine 1;   Drug: dexmedetomidine 2;   Drug: dexmedetomidine 3
25 Recruiting Apollo™ Onyx™ Delivery Micro Catheter Post Market Safety Study
Condition: Arteriovenous Malformations
Intervention: Device: Apollo™ Onyx™ Delivery Micro Catheter
26 Recruiting Bevacizumab Therapy for Brain Arteriovenous Malformation
Condition: Brain Arteriovenous Malformation
Intervention: Drug: Bevacizumab
27 Recruiting Treatment of Brain AVMs (TOBAS) Study
Conditions: Unruptured Brain Arteriovenous Malformation;   Ruptured Brain Arteriovenous Malformation;   Arteriovenous Malformations;   AVM;   BAVM
Interventions: Procedure: Neurosurgery;   Radiation: Radiation therapy;   Procedure: Embolization
28 Recruiting Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations
Condition: Arteriovenous Malformations
Intervention: Drug: Sirolimus
29 Recruiting The Natural History of Prospective Symptomatic Hemorrhage in Adult Patients With Cerebral Cavernous Malformation
Conditions: Cerebral Cavernous Malformation;   Intracerebral Hemorrhage
Intervention:
30 Not yet recruiting A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab
Condition: Von Hippel-Lindau Syndrome
Interventions: Drug: Ranibizumab;   Drug: E10030
31 Recruiting Multimodal Imaging Techniques in Assessing the Surgical Risk for Eloquent Arteriovenous Malformations
Condition: Intracranial Arteriovenous Malformations
Intervention: Procedure: Microsurgical resection of brain AVMs
32 Recruiting Treatment of Cerebral Arteriovenous Malformations With SQUID™ Liquid Embolic Agent
Condition: Cerebral Arteriovenous Malformations
Intervention: Device: SQUID™
33 Recruiting ONYX Evaluation in the Endovascular Treatment of Cerebral Arteriovenous Malformations (cAVM)
Condition: Cerebral Arteriovenous Malformations
Intervention:
34 Recruiting Reperfusion of Pulmonary Arteriovenous Malformations After Embolotherapy
Condition: Pulmonary Arteriovenous Malformations
Intervention: Procedure: Angiography and embolotherapy
35 Not yet recruiting Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil System
Conditions: Visceral Artery Aneurysms;   Arteriovenous Malformations
Intervention: Device: Penumbra Ruby Coil System
36 Recruiting Lymphatic Anomalies Registry
Conditions: Lymphatic Malformation;   Generalized Lymphatic Anomaly (GLA);   Central Conducting Lymphatic Anomaly;   CLOVES Syndrome;   Gorham-Stout Disease ("Disappearing Bone Disease");   Blue Rubber Bleb Nevus Syndrome;   Kaposiform Lymphangiomatosis;   Kaposiform Hemangioendothelioma/Tufted Angioma;   Klippel-Trenaunay Syndrome;   Lymphangiomatosis
Intervention:
37 Recruiting Proton Radiotherapy for Primary Central Nervous System Tumours in Adults
Conditions: Central Nervous System Tumour;   Arteriovenous Malformation
Intervention: Radiation: Proton radiotherapy
38 Not yet recruiting Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs With and Without Airflow Obstruction
Conditions: Pulmonary Arteriovenous Malformations;   Hereditary Hemorrhagic Telangiectasia;   Asthma;   COPD
Intervention: Other: Cardiopulmonary exercise test
39 Recruiting Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs
Conditions: Pulmonary Arteriovenous Malformations;   Hereditary Hemorrhagic Telangiectasia
Interventions: Other: Cardiopulmonary exercise test;   Procedure: Blood test
40 Recruiting Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol
Conditions: Sturge Weber Syndrome;   Port-wine Mark
Interventions: Drug: Timolol;   Drug: Preservative free artificial tear gel.

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-43) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.